Table of Contents Author Guidelines Submit a Manuscript
International Journal of Photoenergy
Volume 2012, Article ID 637429, 9 pages
http://dx.doi.org/10.1155/2012/637429
Review Article

Perspectives on the Role of Photodynamic Therapy in the Treatment of Pancreatic Cancer

1Department of Hepatobiliary Surgery, First Affiliated Hospital of Medical College, Xi'an Jiaotong University, 277 West Yanta Road, Xi'an 710061, Shaanxi Province, China
2Department of Pharmaceutical Sciences, North Dakota State University, Sudro Hall 203, Fargo, ND 58105, USA

Received 15 May 2011; Revised 25 July 2011; Accepted 1 August 2011

Academic Editor: Peter Robertson

Copyright © 2012 Wei Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, R. Siegel, J. Xu, and E. Ward, “Cancer statistics, 2010,” CA Cancer Journal for Clinicians, vol. 60, no. 5, pp. 277–300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Herszényi and Z. Tulassay, “Epidemiology of gastrointestinal and liver tumors,” European Review for Medical and Pharmacological Sciences, vol. 14, no. 4, pp. 249–258, 2010. View at Google Scholar · View at Scopus
  3. C. J. Wray, S. A. Ahmad, J. B. Matthews, and A. M. Lowy, “Surgery for pancreatic cancer: recent controversies and current practice,” Gastroenterology, vol. 128, no. 6, pp. 1626–1641, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. E. H. Castellanos, D. B. Cardin, and J. D. Berlin, “Treatment of early-stage pancreatic cancer,” Oncology, vol. 25, no. 2, pp. 182–189, 2011. View at Google Scholar
  5. C. J. Campen, T. Dragovich, and A. F. Baker, “Management strategies in pancreatic cancer,” American Journal of Health-System Pharmacy, vol. 68, no. 7, pp. 573–584, 2011. View at Publisher · View at Google Scholar
  6. C. M. Moore, D. Pendse, and M. Emberton, “Photodynamic therapy for prostate cancer—a review of current status and future promise,” Nature Clinical Practice Urology, vol. 6, no. 1, pp. 18–30, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. C. A. Robertson, D. H. Evans, and H. Abrahamse, “Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT,” Journal of Photochemistry and Photobiology B, vol. 96, no. 1, pp. 1–8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Alexiades-Armenakas, “Laser-mediated photodynamic therapy,” Clinics in Dermatology, vol. 24, no. 1, pp. 16–25, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Zhao and Y. Y. He, “Recent advances in the prevention and treatment of skin cancer using photodynamic therapy,” Expert Review of Anticancer Therapy, vol. 10, no. 11, pp. 1797–1809, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Jerjes, T. Upile, S. Akram, and C. Hopper, “The surgical palliation of advanced head and neck cancer using photodynamic therapy,” Clinical Oncology, vol. 22, no. 9, pp. 785–791, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. M. A. Wildeman, H. J. Nyst, B. Karakullukcu, and B. I. Tan, “Photodynamic therapy in the therapy for recurrent/persistent nasopharyngeal cancer,” Head & Neck Oncology, vol. 1, article 40, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Chen, A. Pennathur, and J. D. Luketich, “Role of photodynamic therapy in unresectable esophageal and lung cancer,” Lasers in Surgery and Medicine, vol. 38, no. 5, pp. 396–402, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Ayaru, S. G. Bown, and S. P. Pereira, “Photodynamic therapy for pancreatic and biliary tract carcinoma,” International Journal of Gastrointestinal Cancer, vol. 35, no. 1, pp. 1–13, 2005. View at Google Scholar · View at Scopus
  14. S. Jain and R. C. Kockelbergh, “The role of photodynamic diagnosis in the contemporary management of superficial bladder cancer,” BJU International, vol. 96, no. 1, pp. 17–21, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. J. C. Stockert, M. Cañete, A. Juarranz et al., “Porphycenes: Facts and prospects in photodynamic therapy of cancer,” Current Medicinal Chemistry, vol. 14, no. 9, pp. 997–1026, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. I. E. Kochevar and R. W. Redmond, “Photosensitized production of singlet oxygen,” Methods in Enzymology, vol. 319, pp. 20–28, 2000. View at Google Scholar · View at Scopus
  17. H. Kolarova, P. Nevrelova, K. Tomankova, P. Kolar, R. Bajgar, and J. Mosinger, “Production of reactive oxygen species after photodynamic therapy by porphyrin sensitizers,” General Physiology and Biophysics, vol. 27, no. 2, pp. 101–105, 2008. View at Google Scholar · View at Scopus
  18. B. G. Fan and A. Andren-Sandberg, “Photodynamic therapy for pancreatic cancer,” Pancreas, vol. 34, no. 4, pp. 385–389, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Kessel, M. G. H. Vicente, and J. J. Reiners, “Initiation of apoptosis and autophagy by photodynamic therapy,” Lasers in Surgery and Medicine, vol. 38, no. 5, pp. 482–488, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Kroemer, L. Galluzzi, P. Vandenabeele et al., “Classification of cell death: Recommendations of the Nomenclature Committee on Cell Death 2009,” Cell Death and Differentiation, vol. 16, no. 1, pp. 3–11, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. K. S. Samkoe, A. Chen, I. Rizvi et al., “Imaging tumor variation in response to photodynamic therapy in pancreatic cancer xenograft models,” International Journal of Radiation Oncology Biology Physics, vol. 76, no. 1, pp. 251–259, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. Q. Xie, L. Jia, Y. H. Liu, and C. G. Wei, “Synergetic anticancer effect of combined gemcitabine and photodynamic therapy on pancreatic cancer in vivo,” World Journal of Gastroenterology, vol. 15, no. 6, pp. 737–741, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Regula, B. Ravi, J. Bedwell, A. J. MacRobert, and S. G. Bown, “Photodynamic therapy using 5-aminolaevulinic acid for experimental pancreatic cancer—prolonged animal survival,” British Journal of Cancer, vol. 70, no. 2, pp. 248–254, 1994. View at Google Scholar · View at Scopus
  24. P. Mlkvy, H. Messman, A. J. MacRobert et al., “Photodynamic therapy of a transplanted pancreatic cancer model using meta-tetrahydroxyphenylchlorin (mTHPC),” British Journal of Cancer, vol. 76, no. 6, pp. 713–718, 1997. View at Google Scholar · View at Scopus
  25. A. Hajri, S. Coffy, F. Vallat, S. Evrard, J. Marescaux, and M. Aprahamian, “Human pancreatic carcinoma cells are sensitive to photodynamic therapy in vitro and in vivo,” British Journal of Surgery, vol. 86, no. 7, pp. 899–906, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Ketabchi, A. MacRobert, P. M. Speight, and J. H. Bennett, “Induction of apoptotic cell death by photodynamic therapy in human keratinocytes,” Archives of Oral Biology, vol. 43, no. 2, pp. 143–149, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. C. S. M. Ferreira, M. C. Cheung, S. Missailidis, S. Bisland, and J. Gariépy, “Phototoxic aptamers selectively enter and kill epithelial cancer cells,” Nucleic Acids Research, vol. 37, no. 3, pp. 866–876, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Blank and Y. Shiloh, “Programs for cell death: apoptosis is only one way to go,” Cell Cycle, vol. 6, no. 6, pp. 686–695, 2007. View at Google Scholar · View at Scopus
  29. J. Usuda, T. Hirata, S. Ichinose et al., “Tailor-made approach to photodynamic therapy in the treatment of cancer based on Bcl-2 photodamage,” International Journal of Oncology, vol. 33, no. 4, pp. 689–696, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Z. Renno, F. C. Delori, R. A. Holzer, E. S. Gragoudas, and J. W. Miller, “Photodynamic therapy using Lu-Tex induces apoptosis in vitro, and its effect is potentiated by angiostatin in retinal capillary endothelial cells,” Investigative Ophthalmology and Visual Science, vol. 41, no. 12, pp. 3963–3971, 2000. View at Google Scholar · View at Scopus
  31. J. He, M. L. Agarwal, H. E. Larkin, L. R. Friedman, L. Y. Xue, and N. L. Oleinick, “The Induction of Partial Resistance to Photodynamic Therapy by the Protooncogene BCL-2,” Photochemistry and Photobiology, vol. 64, no. 5, pp. 845–852, 1996. View at Google Scholar · View at Scopus
  32. X. Chen, P. Zhao, F. Chen, L. Li, and R. Luo, “Effect and mechanism of 5-aminolevulinic acid-mediated photodynamic therapy in esophageal cancer,” Lasers in Medical Science, vol. 26, no. 1, pp. 69–78, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. C. M. N. Yow, N. K. Mak, A. W. N. Leung, and Z. Huang, “Induction of early apoptosis in human nasopharyngeal carcinoma cells by mTHPC-mediated photocytotoxicity,” Photodiagnosis and Photodynamic Therapy, vol. 6, no. 2, pp. 122–127, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. Z. W. Liu, Y. P. Zhao, Q. Liao, Y. D. Wu, and Y. Zhu, “Relationship between apoptosis induced by 2-butylamino-2-demethoxy-hypocrellin B in human pancreatic cancer cells Capan-1 and photosensitization of mitochondria,” Zhonghua Wai Ke Za Zhi, vol. 44, no. 1, pp. 36–39, 2006. View at Google Scholar · View at Scopus
  35. D. Kessel and Y. Luo, “Photodynamic therapy: a mitochondrial inducer of apoptosis,” Cell Death and Differentiation, vol. 6, no. 1, pp. 28–35, 1999. View at Google Scholar · View at Scopus
  36. Y. -M. Jeong, H. Li, S. Y. Kim et al., “Photo-activated 5-hydroxyindole-3-acetic acid induces apoptosis of prostate and bladder cancer cells,” Journal of Photochemistry and Photobiology B, vol. 103, no. 1, pp. 50–56, 2011. View at Publisher · View at Google Scholar
  37. D. I. O'Brien, K. Nally, R. G. Kelly, T. M. O'Connor, F. Shanahan, and J. O'Connell, “Targeting the Fas/Fas ligand pathway in cancer,” Expert Opinion on Therapeutic Targets, vol. 9, no. 5, pp. 1031–1044, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Olivo and M. Ali-Seyed, “Apoptosis signalling mechanisms in human cancer cells induced by Calphostin-PDT,” International Journal of Oncology, vol. 30, no. 3, pp. 537–548, 2007. View at Google Scholar · View at Scopus
  39. O. Inanami, A. Yoshito, K. Takahashi, W. Hiraoka, and M. Kuwabara, “Effects of BAPTA-AM and forskolin on apoptosis and cytochrome c release in photosensitized Chinese hamster V79 cells,” Photochemistry and Photobiology, vol. 70, no. 4, pp. 650–655, 1999. View at Google Scholar · View at Scopus
  40. J. F. Chiou, Y. H. Wang, M. J. Jou, T. Z. Liu, and C. Y. Shiau, “Verteporfin-photoinduced apoptosis in HepG2 cells mediated by reactive oxygen and nitrogen species intermediates,” Free Radical Research, vol. 44, no. 2, pp. 155–170, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. R. D. Almeida, B. J. Manadas, A. P. Carvalho, and C. B. Duarte, “Intracellular signaling mechanisms in photodynamic therapy,” Biochimica et Biophysica Acta, vol. 1704, no. 2, pp. 59–86, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Galaz, J. Espada, J. C. Stockert et al., “Loss of E-cadherin mediated cell-cell adhesion as an early trigger of apoptosis induced by photodynamic treatment,” Journal of Cellular Physiology, vol. 205, no. 1, pp. 86–96, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Volanti, G. Gloire, A. Vanderplasschen, N. Jacobs, Y. Habraken, and J. Piette, “Downregulation of ICAM-1 and VCAM-1 expression in endothelial cells treated by photodynamic therapy,” Oncogene, vol. 23, no. 53, pp. 8649–8658, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. E. Buytaert, M. Dewaele, and P. Agostinis, “Molecular effectors of multiple cell death pathways initiated by photodynamic therapy,” Biochimica et Biophysica Acta, vol. 1776, no. 1, pp. 86–107, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Zawacka-Pankau, J. Krachulec, I. Grulkowski, K. P. Bielawski, and G. Selivanova, “The p53-mediated cytotoxicity of photodynamic therapy of cancer: recent advances,” Toxicology and Applied Pharmacology, vol. 232, no. 3, pp. 487–497, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Mitsunaga, A. Tsubota, K. Nariai et al., “Early apoptosis and cell death induced by ATX-S10Na (II)-mediated photodynamic therapy are Bax- and p53-dependent in human colon cancer cells,” World Journal of Gastroenterology, vol. 13, no. 5, pp. 692–698, 2007. View at Google Scholar · View at Scopus
  47. D. S. Lim, S. M. Bae, S. Y. Kwak et al., “Adenovirus-mediated p53 treatment enhances photodynamic antitumor response,” Human Gene Therapy, vol. 17, no. 3, pp. 347–352, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. B. W. Jia and X. L. Lian, “Use of photodynamic therapy in malignant lesions of stomach, bile duct, pancreas, colon and rectum,” Hepato-Gastroenterology, vol. 54, no. 75, pp. 718–724, 2007. View at Google Scholar · View at Scopus
  49. T. Yorimitsu and D. J. Klionsky, “Autophagy: molecular machinery for self-eating,” Cell Death and Differentiation, vol. 12, no. 2, pp. 1542–1552, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. G. Kroemer and M. Jäättelä, “Lysosomes and autophagy in cell death control,” Nature Reviews Cancer, vol. 5, no. 11, pp. 886–897, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. G. Kroemer, W. S. El-Deiry, P. Golstein et al., “Classification of cell death: recommendations of the Nomenclature Committee on Cell Death,” Cell Death and Differentiation, vol. 12, no. 2, pp. 1463–1467, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. J. J. Reiners Jr., P. Agostinis, K. Berg, N. L. Oleinick, and D. Kessel, “Assessing autophagy in the context of photodynamic therapy,” Autophagy, vol. 6, no. 1, pp. 7–18, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Criollo, M. C. Maiuri, E. Tasdemir et al., “Regulation of autophagy by the inositol trisphosphate receptor,” Cell Death and Differentiation, vol. 14, no. 5, pp. 1029–1039, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Weyergang, K. Berg, O. Kaalhus, Q. Peng, and P. K. Selbo, “Photodynamic therapy targets the mTOR signaling network in Vitro and in Vivo,” Molecular Pharmaceutics, vol. 6, no. 1, pp. 255–264, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. D. Kessel and A. S. Arroyo, “Apoptotic and autophagic responses to Bcl-2 inhibition and photodamage,” Photochemical and Photobiological Sciences, vol. 6, no. 12, pp. 1290–1295, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. P. Carmeliet and R. K. Jain, “Angiogenesis in cancer and other diseases,” Nature, vol. 407, no. 6801, pp. 249–257, 2000. View at Publisher · View at Google Scholar · View at Scopus
  57. V. H. Fingar, T. J. Wieman, S. A. Wiehle, and P. B. Cerrito, “The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion,” Cancer Research, vol. 52, no. 18, pp. 4914–4921, 1992. View at Google Scholar · View at Scopus
  58. J. H. Woodhams, L. Kunz, S. G. Bown, and A. J. MacRobert, “Correlation of real-time haemoglobin oxygen saturation monitoring during photodynamic therapy with microvascular effects and tissue necrosis in normal rat liver,” British Journal of Cancer, vol. 91, no. 4, pp. 788–794, 2004. View at Google Scholar · View at Scopus
  59. L. B. Li and R. C. Luo, “Effect of drug-light interval on the mode of action of Photofrin photodynamic therapy in a mouse tumor model,” Lasers in Medical Science, vol. 24, no. 4, pp. 597–603, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. R. Bhuvaneswari, G. Y. Yuen, S. K. Chee, and M. Olivo, “Hypericin-mediated photodynamic therapy in combination with Avastin (bevacizumab) improves tumor response by downregulating angiogenic proteins,” Photochemical and Photobiological Sciences, vol. 6, no. 12, pp. 1275–1283, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. Q. Zhou, M. Olivo, K. Y. K. Lye, S. Moore, A. Sharma, and B. Chowbay, “Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models,” Cancer Chemotherapy and Pharmacology, vol. 56, no. 6, pp. 569–577, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. R. Bhuvaneswari, Y. Y. Y. Gan, K. K. L. Yee, K. C. Soo, and M. Olivo, “Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma,” International Journal of Molecular Medicine, vol. 20, no. 4, pp. 421–428, 2007. View at Google Scholar · View at Scopus
  63. J. Reyal, “Arterial flow focalization could increase tissue oxygen partial pressure, or trigger endothelial shear stress—a new concept to overcome cancer hypoxia-induced radiotherapy resistance, or stimulate liver regeneration during fulminant hepatitis,” Medical Hypotheses, vol. 74, no. 2, pp. 301–308, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. B. W. Henderson and T. J. Dougherty, “How does photodynamic therapy work?” Photochemistry and Photobiology, vol. 55, no. 1, pp. 145–157, 1992. View at Google Scholar · View at Scopus
  65. M. L. Agarwal, H. E. Larkin, S. I. A. Zaidi, H. Mukhtar, and N. L. Oleinick, “Phospholipase activation triggers apoptosis in photosensitized mouse lymphoma cells,” Cancer Research, vol. 53, no. 24, pp. 5897–5902, 1993. View at Google Scholar · View at Scopus
  66. S. O. Gollnick, S. S. Evans, H. Baumann et al., “Role of cytokines in photodynamic therapy-induced local and systemic inflammation,” British Journal of Cancer, vol. 88, no. 11, pp. 1772–1779, 2003. View at Publisher · View at Google Scholar · View at Scopus
  67. I. Cecic, B. Stott, and M. Korbelik, “Acute phase response-associated systemic neutrophil mobilization in mice bearing tumors treated by photodynamic therapy,” International Immunopharmacology, vol. 6, no. 8, pp. 1259–1266, 2006. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Korbelik, I. Cecic, S. Merchant, and J. Sun, “Acute phase response induction by cancer treatment with photodynamic therapy,” International Journal of Cancer, vol. 122, no. 6, pp. 1411–1417, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. M. Korbelik, J. Sun, and I. Cecic, “Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response,” Cancer Research, vol. 65, no. 3, pp. 1018–1026, 2005. View at Google Scholar · View at Scopus
  70. W. J. A. de Vree, M. C. Essers, H. S. de Bruijn, W. M. Star, J. F. Koster, and W. Sluiter, “Evidence for an important role of neutrophils in the efficacy of photodynamic therapy in vivo,” Cancer Research, vol. 56, no. 13, pp. 2908–2911, 1996. View at Google Scholar · View at Scopus
  71. S. O. Gollnick, B. Owczarczak, and P. Maier, “Photodynamic therapy and anti-tumor immunity,” Lasers in Surgery and Medicine, vol. 38, no. 5, pp. 509–515, 2006. View at Publisher · View at Google Scholar · View at Scopus
  72. M. J. Walport, “Advances in immunology: complement (first of two parts),” The New England Journal of Medicine, vol. 344, no. 14, pp. 1058–1066, 2001. View at Publisher · View at Google Scholar · View at Scopus
  73. B. Stott and M. Korbelik, “Activation of complement C3, C5, and C9 genes in tumors treated by photodynamic therapy,” Cancer Immunology, Immunotherapy, vol. 56, no. 5, pp. 649–658, 2007. View at Publisher · View at Google Scholar · View at Scopus
  74. M. Korbelik and I. Cecic, “Complement activation cascade and its regulation: relevance for the response of solid tumors to photodynamic therapy,” Journal of Photochemistry and Photobiology B, vol. 93, no. 1, pp. 53–59, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. I. Cecic and M. Korbelik, “Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors,” Cancer Letters, vol. 183, no. 1, pp. 43–51, 2002. View at Publisher · View at Google Scholar · View at Scopus
  76. P. Mroz, A. Szokalska, M. X. Wu, and M. R. Hamblin, “Photodynamic therapy of tumors can lead to development of systemic antigen-specific immune response,” PLoS ONE, vol. 5, no. 12, Article ID e15194, 2010. View at Publisher · View at Google Scholar · View at Scopus
  77. A. P. Castano, P. Mroz, M. X. Wu, and M. R. Hamblin, “Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 14, pp. 5495–5500, 2008. View at Publisher · View at Google Scholar · View at Scopus
  78. S. G. Bown, A. Z. Rogowska, D. E. Whitelaw et al., “Photodynamic therapy for cancer of the pancreas,” Gut, vol. 50, no. 4, pp. 549–557, 2002. View at Publisher · View at Google Scholar · View at Scopus
  79. A. M. Abulafi, J. T. Allardice, N. S. Williams, N. Van Someren, C. P. Swain, and C. Ainley, “Photodynamic therapy for malignant tumours of the ampulla of Vater,” Gut, vol. 36, no. 6, pp. 853–856, 1995. View at Google Scholar · View at Scopus
  80. W. W. Tseng, R. E. Saxton, A. Deganutti, and C. D. Liu, “Infrared laser activation of indocyanine green inhibits growth in human pancreatic cancer,” Pancreas, vol. 27, no. 3, pp. e42–e45, 2003. View at Google Scholar · View at Scopus
  81. Z. Huang, “A review of progress in clinical photodynamic therapy,” Technology in Cancer Research and Treatment, vol. 4, no. 3, pp. 283–293, 2005. View at Google Scholar · View at Scopus
  82. L. Ayaru, J. Wittmann, A. J. MacRobert, M. Novelli, S. G. Bown, and S. P. Pereira, “Photodynamic therapy using verteporfin photosensitization in the pancreas and surrounding tissues in the Syrian golden hamster,” Pancreatology, vol. 7, no. 1, pp. 20–27, 2007. View at Publisher · View at Google Scholar · View at Scopus
  83. T. E. Yusuf, K. Matthes, and W. R. Brugge, “EUS-guided photodynamic therapy with verteporfin for ablation of normal pancreatic tissue: a pilot study in a porcine model (with video),” Gastrointestinal Endoscopy, vol. 67, no. 6, pp. 957–961, 2008. View at Publisher · View at Google Scholar · View at Scopus
  84. H. I. Pass, T. F. DeLaney, Z. Tochner et al., “Intrapleural photodynamic therapy: results of a phase I trial,” Annals of Surgical Oncology, vol. 1, no. 1, pp. 28–37, 1994. View at Publisher · View at Google Scholar · View at Scopus
  85. T. Momma, M. R. Hamblin, H. C. Wu, and T. Hasan, “Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: local control and distant metastasis,” Cancer Research, vol. 58, no. 23, pp. 5425–5431, 1998. View at Google Scholar · View at Scopus
  86. P. J. O. Nuutinen, P. T. Chatlani, J. Bedwell, A. J. MacRobert, D. Phillips, and S. G. Bown, “Distribution and photodynamic effect of disulphonated aluminium phthalocyanine in the pancreas and adjacent tissues in the Syrian golden hamster,” British Journal of Cancer, vol. 64, no. 6, pp. 1108–1115, 1991. View at Google Scholar · View at Scopus
  87. F. S. De Rosa and M. V. L. B. Bentley, “Photodynamic therapy of skin cancers: sensitizers, clinical studies and future directives,” Pharmaceutical Research, vol. 17, no. 12, pp. 1447–1455, 2000. View at Publisher · View at Google Scholar · View at Scopus
  88. B. C. Wilson, “Potential applications of photodynamic therapy in regenerative medicine,” The Journal of Craniofacial Surgery, vol. 14, no. 3, pp. 278–283, 2003. View at Google Scholar · View at Scopus